Blog

Embryonic stem cells hold key to beta-cell transplantation in diabetes, but hurdles remain – Healio

Embryonic stem cells hold key to beta-cell transplantation in diabetes, but hurdles remain
Healio
Speaking during a presidential plenary discussion on the creation of human pancreatic beta cells for study and treatment of diabetes, Douglas A. Melton, PhD, co-director of the Harvard Stem Cell Institute and an investigator with the Howard Hughes
International Stem Cell Corp. (ISCO) Bypasses the Moral Dilemma Associated with Stem CellsInvestorIdeas.com (press release)



all 2 news articles »

2016-04-01
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.